The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action

被引:93
作者
Honeywell-Nguyen, PL [1 ]
Bouwstra, JA [1 ]
机构
[1] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Dept Pharmaceut Technol, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands
关键词
transdermal delivery; elastic vesicles; pergolide;
D O I
10.1016/S0168-3659(02)00415-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper reports the in vitro transport of pergolide from L-595-PEG-8-L elastic vesicle formulations. Several aspects of vesicular delivery were studied in order to elucidate the possible mechanisms of action and to establish the optimal conditions and drug candidates for usage with L-595-PEG-8-L elastic vesicles. All studies were performed using human skin and flow-through Franz diffusion cells. Pergolide was chosen as model drug. The findings show that there was a strong correlation between the drug incorporation to saturated levels and the drug transport, both of which were influenced by the pH of the drug-vesicular system. The optimal pH was found to be 5.0, giving the highest drug incorporation as well as the highest drug transport. Non-occlusive co-treatment with elastic vesicles improved the skin delivery of pergolide compared to the non-occlusive,buffer control by more than 2-fold. However, non-occlusive pre-treatment of skin with empty vesicles did not enhance drug transport. Occlusion improved drug transport from both elastic vesicle as well as buffer solutions due to the fact that water is an excellent penetration enhancer for pergolide. However, in contrast to non-occlusive application, the action of the elastic vesicles themselves was diminished, as occlusive treatments with elastic vesicles showed a lower flux compared to occlusive treatment with the buffer control. Hence, the highest pergolide skin permeation in this study was obtained from an occluded saturated buffer solution, giving a steady-state flux of 137.9 ng/h cm(-2). The volume of application did not have any effect on the drug transport. In conclusion, these results showed no evidence that a penetration enhancing effect is the main mechanism of action. The pH of the drug-vesicular system is an important factor to consider when optimising elastic vesicle delivery systems. Occlusion reduces the actions of elastic vesicles, but could increase the pergolide transport since water is a good penetration enhancer for this particular drug. Based on the results obtained, a mechanism of action for the elastic vesicles was proposed. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 23 条
[1]   Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol [J].
Agarwal, R ;
Katare, OP ;
Vyas, SP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 228 (1-2) :43-52
[2]   THE PREPARATION AND PROPERTIES OF NIOSOMES NON-IONIC SURFACTANT VESICLES [J].
BAILLIE, AJ ;
FLORENCE, AT ;
HUME, LR ;
MUIRHEAD, GT ;
ROGERSON, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (12) :863-868
[3]   LIPID VESICLES PENETRATE INTO INTACT SKIN OWING TO THE TRANSDERMAL OSMOTIC GRADIENTS AND HYDRATION FORCE [J].
CEVC, G ;
BLUME, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1104 (01) :226-232
[4]   Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin [J].
Cevc, G ;
Gebauer, D ;
Stieber, J ;
Schätzlein, A ;
Blume, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1368 (02) :201-215
[5]   Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery [J].
Cevc, G .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1996, 13 (3-4) :257-388
[6]   THE INFLUENCE OF IN-VIVO TREATMENT OF SKIN WITH LIPOSOMES ON THE TOPICAL ABSORPTION OF A HYDROPHILIC AND A HYDROPHOBIC DRUG IN-VITRO [J].
DUPLESSIS, J ;
WEINER, N ;
MULLER, DG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 103 (02) :R1-R5
[7]   Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies [J].
El Maghraby, GMM ;
Williams, AC ;
Barry, BW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (10) :1123-1134
[8]   Effect of liposomes and niosomes on skin permeation of enoxacin [J].
Fang, JY ;
Hong, CT ;
Chiu, WT ;
Wang, YY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 219 (1-2) :61-72
[9]  
Fresta M, 1997, J CONTROL RELEASE, V44, P141, DOI 10.1016/S0168-3659(96)01519-2
[10]   Lecithin vesicular carriers for transdermal delivery of cyclosporin A [J].
Guo, JX ;
Ping, QN ;
Sun, GQ ;
Jiao, CH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 194 (02) :201-207